monovalent bispecific IgG antibodies through novel electrostatic steering mutations at the CH1-CL interface
External Resource: Annotation
SAbDab Antibody Annotation SAbDab Database Homepage
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|---|---|---|---|---|
| B [auth H], D [auth B] | Heavy Chain | IGHV3 | - | - | SAbDab (2026-02-27) |
| A [auth L], C [auth A] | Light Chain | IGKV1 | Kappa | - | SAbDab (2026-02-27) |
Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage
| Chain | Name | Target | Provenance Source |
|---|---|---|---|
| B [auth H], D [auth B] | Anvatabart | ERBB2/CD340/HER2, CD3E, SIRPA, TNFRSF9/CD137/4-1BB | Therapeutic SAbDab (2026-02-27) |
| A [auth L], C [auth A] | Trastuzumab | ERBB2/CD340/HER2, SIRPA, TNFRSF9/CD137/4-1BB, CD3E | Therapeutic SAbDab (2026-02-27) |
